Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21

Br J Cancer. 1996 Jul;74(1):115-9. doi: 10.1038/bjc.1996.324.

Abstract

Forty-nine ovarian tumours were examined for loss of heterozygosity (LOH) on chromosome 5 using eight microsatellite markers spanning both arms, including one at the APC locus. LOH on 5q was a frequent event, detectable in 23 of 49 (47%) tumours, whereas 5p LOH was detected in only 1 of 22 tumours (5%). Six tumours showed partial LOH on 5q, enabling the candidate region to be localised to a 22 cM region proximal to APC, flanked by D5S424 and D5S644. An association was found between 5q LOH and TP53 mutation, with 18 of 23 (78%) tumours with LOH on 5q also harbouring a TP53 mutation. LOH on 5q was observed in 6 of 18 (33%) stage I tumours, suggesting that it may be an early event in the molecular pathogenesis of certain ovarian carcinomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Chromosomes, Human, Pair 5*
  • DNA, Neoplasm / genetics
  • DNA, Satellite / genetics
  • Female
  • Gene Deletion*
  • Genes, Tumor Suppressor*
  • Genes, p53*
  • Heterozygote
  • Humans
  • Molecular Sequence Data
  • Mutation*
  • Neoplasm Staging
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / pathology
  • Polymorphism, Genetic
  • Polymorphism, Single-Stranded Conformational

Substances

  • DNA, Neoplasm
  • DNA, Satellite